Investment Rating - The report maintains a "Buy" rating for the company [1] Core Views - The company is expected to benefit from the clear trend of range-extended vehicle expansion, with a solid foundation for 2025 despite competition [6][19] - The company has multiple strategies to respond to competition, including production capacity increases and product upgrades [19][25] - The company is well-positioned to capture market share in the 200,000 to 300,000 RMB price range for pure electric vehicles [40][48] - The company has a competitive advantage in intelligent driving technology, with rapid feature iterations and early releases [52] Summary by Sections 1. Agile Adjustments and Efficiency - The company has adjusted its pure electric strategy and maintains leading operational efficiency, with a gross margin around 20% [9] - Despite challenges, the company’s overall operations remain stable, with a significant recovery in profitability expected in the latter half of 2024 [10][16] 2. Range-Extended Vehicle Expansion - The company is expected to benefit from the expansion of range-extended vehicles, with L6 sales projected to grow over 50% in 2025 [19][25] - The competitive landscape is manageable, with the company’s L series facing limited direct competition [19][20] 3. Pure Electric Strategy - The company plans to leverage the large market potential in the 200,000 to 300,000 RMB price range for pure electric vehicles, where penetration rates are high [41][48] - The company is prepared to adjust its pure electric vehicle launch schedule based on market conditions [46] 4. Intelligent Driving Advantage - The company has a high ownership rate of intelligent driving vehicles and is rapidly iterating features, with plans to enhance the driving experience significantly by 2025 [52] - The company’s intelligent driving training data volume is substantial, supporting faster iterations and improvements [52]

Investment Rating - Maintains a "Buy" rating with a 6-month outlook [5] Core Views - The company is in a critical year of its fifth five-year plan (2022-2027), with a strong track record of exceeding performance targets annually [1] - The company operates 40 self-owned schools with a capacity for 180,000 students, currently serving 90,000, indicating significant growth potential [1] - The managed school business is expanding, with over 100 school segments in the pipeline and an additional 30 segments expected by September [1] - The company's diversified business segments, including study tours and educational technology, are thriving, with strong market positioning and potential for external expansion [2] - The company's competition training system has produced over 60 provincial-level award winners and multiple national team members, with successful external commercialization of its competition courses [3] - The company's AI-driven educational products have demonstrated significant effectiveness, with a 36-point average score improvement and an 86% improvement rate among students in a pilot program [2] Financial Projections - Expected revenues for FY25-27 are RMB 4.6 billion, RMB 6.4 billion, and RMB 8.8 billion, respectively [5] - Adjusted net profits for FY25-27 are projected to be RMB 800 million, RMB 1.1 billion, and RMB 1.4 billion, respectively [5] - EPS for FY25-27 is forecasted to be RMB 0.38, RMB 0.51, and RMB 0.67, respectively [5] Business Segments - The company's study tour business integrates knowledge learning with practical experiences, covering various fields such as history, natural sciences, technology, and arts, attracting top private schools for collaboration [2] - The educational technology platform, "Cloud Platform," has successfully implemented AI in classrooms and study rooms, with a notable pilot program showing a 97% university admission rate among participants [2] - The competition training system has been standardized and successfully exported, with a recent contract signed with a school in Fujian for competition course services [3] Market Performance - The company's stock price has shown significant growth, with a 34% increase over the past year, outperforming the Hang Seng Index [7]

Investment Rating - The report assigns a "Buy" rating to the company with a target price of HKD 9.5, while the current share price is HKD 5.4 [4][6]. Core Insights - The company is a leading private vaccine enterprise in China, with 8 commercialized products and 22 vaccines in development, expecting 1-2 new products to be launched each year over the next three years [1][2]. - The company has a strong pipeline covering the world's top ten vaccine varieties, with three products in the final stages of approval: PCV13, PPSV23, and an updated rabies vaccine [3][4]. - The Chinese vaccine market is experiencing rapid growth, projected to reach CNY 215.7 billion by 2030, driven by increased policy support and innovation [4][55]. Summary by Sections Company Overview - The company is a major private vaccine manufacturer in China, holding four wholly-owned licensed vaccine production enterprises and three central vaccine research institutes, making it one of the two human vaccine companies with P3 laboratory resources in China [2][13]. - The company is the largest supplier of hepatitis B vaccines globally and the second-largest supplier of human rabies vaccines in China, with a market share of 45.4% and 18.1% respectively [2][29]. Product Pipeline - The company has 22 vaccines in development across 14 disease areas, with 9 products having obtained 17 clinical approvals [3][33]. - Key products nearing market approval include PCV13, expected to be approved by Q4 2025, and PPSV23, anticipated for 2026 [3][36]. Market Dynamics - The Chinese vaccine market is growing faster than the global market, with a CAGR of 20.3% from 2015 to 2021, and is expected to continue expanding due to rising vaccination awareness and new product introductions [4][55]. - The market is characterized by high entry barriers and stable competition, with only 34 vaccine manufacturers in China, of which 28 have approval records [57][61]. Financial Projections - Revenue forecasts for 2024-2026 are CNY 1.25 billion, CNY 1.34 billion, and CNY 3.06 billion respectively, with net profits projected to turn positive by 2026 [4][64]. - The company is expected to see significant revenue growth driven by new product launches and increased market penetration [4][64].

Investment Rating - The investment rating for the company is "Outperform the Market" (maintained) [1][3] Core Views - The company reported a robust performance in Q4 2024, with the main brand's offline retail sales growing approximately 10%, children's clothing sales increasing by 10-15%, and e-commerce sales rising by 30-35% [2][3] - The growth in children's clothing and e-commerce has accelerated compared to the previous quarter, indicating a positive trend in consumer demand [3][4] - The company continues to launch competitive new products, including winter down jackets and various running shoes, enhancing consumer experience [5][6] - The financial outlook has been slightly adjusted downward for 2025-2026 due to macroeconomic uncertainties, with projected net profits of 1.14 billion, 1.30 billion, and 1.46 billion yuan for 2024-2026, reflecting year-on-year growth rates of 18.1%, 14.3%, and 12.4% respectively [3][7] Summary by Sections Retail Performance - In Q4 2024, the adult apparel offline sales grew by about 10%, children's apparel by 10-15%, and e-commerce by 30-35%, with both children's and e-commerce sales accelerating compared to Q3 [3][4] Product Development - The company has introduced multiple new products, including the "ULTRA series" down jackets and various running shoes, which have been well-received in the market [5][6] Financial Forecast - The company expects net profits to be 1.14 billion, 1.30 billion, and 1.46 billion yuan for 2024-2026, with corresponding year-on-year growth rates of 18.1%, 14.3%, and 12.4% [3][7] - The target price remains at 4.5-5.1 HKD, corresponding to a PE ratio of 7-8x for 2025 [3][7]

证券研究报告·海外公司深度·食物饮品(HS) 中烟香港（06055.HK） 中烟体系唯一烟草上市公司，资源整合市值 显化空间较大 买入（首次） | [Table_EPS] 盈利预测与估值 | 2022A | 2023A | 2024E | 2025E | 2026E | | --- | --- | --- | --- | --- | --- | | 营业总收入（百万元） | 8324 | 11836 | 13277 | 14328 | 15318 | | 同比(%) | 3.23 | 42.19 | 12.17 | 7.92 | 6.91 | | 归母净利润（百万元） | 374.90 | 598.77 | 806.40 | 925.21 | 1,017.50 | | 同比(%) | (46.66)* | 59.71 | 34.68 | 14.73 | 9.97 | | EPS-最新摊薄（元/股） | 0.54 | 0.87 | 1.17 | 1.34 | 1.47 | | P/E（现价&最新摊薄） | 40.87 | 25.59 | 19.00 | 16.56 | 15.06 | *注：剔除收购中烟巴西产生 ...

Investment Rating - Maintains a "Buy" rating with a target price of HKD 66 0, implying a potential upside of 23 8% from the current price of HKD 53 3 [1][4] Core Views - The company's management has raised the 2024 full-year performance guidance, expecting revenue growth of around 50% and net profit growth of around 40% [1] - The company's main brand, Kefumei, achieved a GMV growth of 78 1% in 2024, driven by strong performance during the "Double 11" shopping festival and new product launches [1] - The company has raised its 2024 performance guidance three times, reflecting strong confidence in achieving its targets [2] - The company is expected to maintain high growth in 2025, driven by the expansion of key products and improved brand strength of its two major brands, Kefumei and Kelijing [2] - The company's medical aesthetic products are expected to be approved as scheduled, with the injection recombinant collagen product for eye wrinkles expected to be approved in Q1 2025 [3] Financial Performance and Forecasts - Revenue for 2024E is expected to reach RMB 5,377 million, a 52 6% YoY increase, with net profit expected to reach RMB 2,044 million, a 40 8% YoY increase [9] - The company's gross margin is expected to remain stable at around 82 3% in 2024E, with an operating margin of 42 4% [10] - The company's ROE is expected to be 34 7% in 2024E, gradually declining to 32 4% by 2026E [9] - The company's PE ratio is expected to decrease from 24 6x in 2024E to 15 0x in 2026E, reflecting strong earnings growth [9] Product and Brand Performance - Kefumei's GMV grew by 78 1% in 2024, with a growth rate of over 80% during the "Double 11" period [1] - Kelijing's GMV grew by over 150% during the "Double 11" period, driven by core products such as the Pong Pong Essence and Collagen Series [1] - The new product, Focus Cream, launched in 2024, has contributed to Kefumei's growth, providing a new growth driver beyond the Collagen Stick [1] Market and Industry Context - The company's stock price has shown strong performance, with a 52-week range of HKD 28 5 to HKD 58 0, and a current market capitalization of HKD 54,804 million [4] - The company's daily average trading volume over the past three months was HKD 164 2 million, indicating strong market interest [4] - The company is part of the cosmetics industry, with peers such as Proya and Shanghai Jahwa also showing strong performance [15]

Investment Rating - Buy rating with a target price of HKD 7.03, implying a 26.7% upside from the current price of HKD 5.5 [4][7] Core Views - The company's Q4 2024 performance was strong, with Saucony growing 50% YoY [2][7] - Xtep's main brand retail sales grew high single-digit YoY in 2024, while Saucony exceeded expectations with over 60% growth [7] - Full-year 2024 profit is expected to achieve 20% growth target [7] - The company is optimistic about 2025 performance, expecting double-digit growth [7] Financial Performance - Revenue is forecasted to grow from RMB 14,712 million in 2024E to RMB 16,676 million in 2026E, representing a 9.4% CAGR [3] - Net profit is projected to increase from RMB 1,242 million in 2024E to RMB 1,576 million in 2026E, a 14.1% CAGR [3] - Gross margin is expected to improve from 40.9% in 2022 to 43.8% in 2026 [8] - ROE is forecasted to rise from 11.4% in 2022 to 14.9% in 2026 [8] Business Development - Xtep main brand: - Continuing to open larger stores and close smaller ones to improve store efficiency [7] - Over 60% of stores are 9th generation stores [7] - Expanding internationally, focusing on Southeast Asia, Middle East, Russia, and cross-border e-commerce [7] - Saucony: - Estimated to exceed RMB 1 billion in scale in 2024 [7] - Store efficiency estimated at RMB 300,000-500,000+ [7] - Plans to open flagship stores in tier 1 cities and expand to tier 2-3 cities [7] - Long-term operating margin target of 20%+ [7] Valuation - Current PE ratio: 10.5x (2024E), 9.5x (2025E), 8.4x (2026E) [3] - Target price of HKD 7.03 represents 12x 2025E EPS [7] - Dividend yield expected to increase from 4.8% in 2024E to 6.0% in 2026E [3]

Investment Rating - The report initiates coverage on Tianneng Power (00819) with a "Buy" rating and a target price of HKD 10.02, based on a 2025 PE of 6x [5][68] Core Views - Tianneng Power is a leading player in the lead-acid battery market for electric two-wheelers, with a market share exceeding 40% in China [3][12] - The lead-acid battery market is expected to benefit from the recovery of the electric two-wheeler industry, driven by policies such as the new national standard and trade-in programs [1][12] - The report forecasts that the lead-acid battery market for two- and three-wheelers in China will reach 323GWh by 2030, with a market size of RMB 113.1 billion [2][34] - Tianneng Power's lead-acid battery business has a high ROE, and the company is refocusing on this segment after reducing capital expenditure in the lithium battery business [4][56] Industry Analysis - Lead-acid batteries remain the dominant choice for electric two-wheelers due to their safety, economic value, and mature after-sales service network [2][30] - The penetration rate of lithium batteries in new electric two-wheelers is less than 10%, and lead-acid batteries are expected to maintain their leading position [2][29] - The new national standard for electric bicycles may relax weight limits, potentially increasing the battery capacity of lead-acid batteries [26][34] - Trade-in policies encourage the replacement of lithium batteries with lead-acid batteries, with additional subsidies of RMB 100 for such replacements [27][29] Company Strengths - Tianneng Power has a strong distribution network with over 400,000 terminal stores and partnerships with more than 3,000 distributors [4][51] - The company's lead-acid battery business has a high ROE, with historical ROE levels of 25% and 28% in 2019 and 2020, respectively [4][56] - Tianneng Power's lead-acid battery business has a consumer goods attribute, with 75% of its products sold directly to end consumers [4][51] - The company has a significant cost advantage in lead-acid batteries due to economies of scale and efficient production capabilities [49][54] Financial Projections - Revenue for 2024-2026 is projected to be RMB 88.63 billion, RMB 94.45 billion, and RMB 101.16 billion, with year-on-year growth rates of -12%, 14%, and 12%, respectively [5][64] - Net profit for 2024-2026 is expected to be RMB 1.39 billion, RMB 2 billion, and RMB 2.38 billion, with year-on-year growth rates of -24%, 44%, and 19%, respectively [5][64] - The lead-acid battery business is expected to generate revenue of RMB 37.33 billion, RMB 42.93 billion, and RMB 48.08 billion in 2024-2026, with growth rates of -12%, 15%, and 12%, respectively [66][67] Market Position and Competition - Tianneng Power holds a leading position in the lead-acid battery market for electric two-wheelers, with a market share of over 40% [3][12] - The company's main competitors include Chaowei Power, which has a lower gross margin but higher net margin compared to Tianneng Power [45][46] - Tianneng Power's lead-acid battery business has a higher net margin than Chaowei Power, attributed to better cost control and economies of scale [45][46]

Investment Rating - The report assigns a positive investment rating to Laopu Gold, indicating strong growth potential and a favorable market position [17][91]. Core Insights - Laopu Gold has demonstrated exceptional performance with a stock price increase of 385% since its listing, significantly outperforming the Hong Kong consumer sector [18]. - The company achieved revenue and net profit growth of 148% and 198% respectively in the first half of 2024, driven by brand recognition and rising gold prices [54][61]. - The report highlights Laopu Gold's unique positioning in the high-end jewelry market, focusing on traditional craftsmanship and emotional value, appealing particularly to younger consumers [13][69]. Summary by Sections Company Performance - Laopu Gold's revenue for 2023 reached 3.18 billion RMB, with a compound annual growth rate (CAGR) of 58.6% from 2021 to 2023 [61]. - The company maintained a stable gross margin of approximately 41% over the past three years, indicating effective cost management [61]. - The average single-store revenue in 2023 was 100 million RMB, with a 113% increase in the first half of 2024 compared to the previous year [28][61]. Competitive Advantages - Laopu Gold is recognized for its unique product designs and high-end branding, which differentiate it from competitors in the jewelry market [24][69]. - The company operates a self-owned store model, allowing for better control over product quality and customer service, which enhances brand image [77]. - Laopu Gold's focus on high-priced products, with 65% of sales coming from items priced between 10,000 and 50,000 RMB, positions it well in the luxury segment [73]. Market Overview - The Chinese jewelry market has shown robust growth, with a projected CAGR of 6.8% from 2023 to 2028, reaching a total sales revenue of 1.14 trillion RMB by 2028 [37]. - Gold products dominate the market, accounting for 63.2% of the total jewelry market share in 2023, with a market size of 518 billion RMB [37][40]. - Despite short-term demand fluctuations due to rising gold prices, Laopu Gold has managed to sustain strong performance, indicating resilience in its business model [49][54]. Future Growth Potential - Laopu Gold currently operates 36 stores, with significant room for expansion, potentially doubling its store count in the coming years [26][84]. - The company is well-positioned to tap into overseas markets, particularly in regions with significant Chinese populations, such as Singapore and the United States [28][87]. - The report forecasts continued strong growth, with net profit expected to reach 1.1 billion RMB in 2024 and 1.5 billion RMB in 2025 [91].

Investment Rating - The report maintains a "Buy" rating for the company, with a current price of HKD 15.48 and a target value of HKD 19.11 [5]. Core Views - The company has partnered with the Chinese Olympic Committee, which is expected to enhance its brand value. It will provide official sportswear for major events from 2025 to 2028, including the Winter Olympics and Asian Games [10]. - The company is anticipated to achieve stable growth in 2025, with improvements in discount and gross margin. Despite increased marketing expenses, the net profit margin is expected to remain above 10% [10]. - The company is focusing on expanding its store network, particularly through direct sales, and is expected to launch more cost-effective products in response to consumer trends [10]. - The forecast for net profit from 2024 to 2026 is CNY 30.7 billion, CNY 30.4 billion, and CNY 33.7 billion, respectively. The report assigns a PE ratio of 15 for 2025, leading to a target value of HKD 19.11 per share [10]. Financial Summary - Revenue is projected to grow from CNY 25.803 billion in 2022 to CNY 30.306 billion in 2026, with a growth rate of 14.3% in 2022, slowing to 6.0% by 2026 [4][14]. - EBITDA is expected to increase from CNY 5.162 billion in 2022 to CNY 6.906 billion in 2026, with a notable dip in 2023 [4][14]. - The net profit attributable to shareholders is forecasted to decline from CNY 4.064 billion in 2022 to CNY 3.374 billion in 2026, reflecting a challenging market environment [4][14]. - The company's EPS is projected to decrease from CNY 1.54 in 2022 to CNY 1.31 in 2026, indicating a potential decline in profitability [4][14]. Key Financial Ratios - The report highlights a decrease in ROE from 16.7% in 2022 to 10.1% in 2025, suggesting a decline in return on equity [13]. - The net profit margin is expected to decrease from 15.7% in 2022 to 11.1% in 2026, indicating potential profitability challenges [13]. - The company's debt-to-asset ratio is projected to improve from 27.7% in 2022 to 23.8% in 2026, reflecting a strengthening balance sheet [13].